Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)
China · Delayed Price · Currency is CNY 35.70
+1.41 (4.11%)
Apr 15, 2026, 3:04 PM CST
SHE:002422 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 1,702 | 2,936 | 2,456 | 1,705 | 1,103 |
Depreciation & Amortization | 1,369 | 1,282 | 1,244 | 1,185 | 1,218 |
Other Amortization | 51.7 | 16.7 | 21.74 | 13.11 | 7.55 |
Loss (Gain) From Sale of Assets | -5.32 | -0.81 | -2.63 | -5.4 | 7.94 |
Asset Writedown & Restructuring Costs | 15.44 | 65.85 | 58.62 | 1.93 | 5.26 |
Loss (Gain) From Sale of Investments | -238.02 | -364.88 | -373.58 | -244.68 | -220.34 |
Provision & Write-off of Bad Debts | 34.82 | 73.41 | 36.21 | 47.75 | 36.82 |
Other Operating Activities | 424.15 | 672.17 | 647.31 | 535.93 | 357.07 |
Change in Accounts Receivable | -37.97 | -27.76 | 1,088 | -905.52 | 625.71 |
Change in Inventory | -158.49 | -84.66 | -645.26 | 168.36 | 107.42 |
Change in Accounts Payable | -676.42 | -173.99 | 313.96 | 579.36 | -365.49 |
Change in Other Net Operating Assets | 174.67 | 178.55 | 218.55 | 71.31 | - |
Operating Cash Flow | 2,642 | 4,493 | 5,337 | 3,127 | 2,847 |
Operating Cash Flow Growth | -41.19% | -15.82% | 70.68% | 9.83% | 28.28% |
Capital Expenditures | -1,622 | -1,678 | -1,769 | -896.7 | -990.56 |
Sale of Property, Plant & Equipment | 10.8 | 8.36 | 1.28 | 12.72 | 7.98 |
Cash Acquisitions | -2.35 | -2.51 | - | - | - |
Divestitures | 11.9 | -40.52 | 80.79 | 5.93 | -30.14 |
Investment in Securities | 143.36 | -316.01 | -1,808 | -89.08 | -578.99 |
Other Investing Activities | 170.52 | 209.57 | 124.55 | 110.03 | 61.92 |
Investing Cash Flow | -1,288 | -1,819 | -3,370 | -857.1 | -1,530 |
Long-Term Debt Issued | 4,657 | 4,914 | 4,028 | 10,358 | 9,004 |
Long-Term Debt Repaid | -4,736 | -6,720 | -7,319 | -10,641 | -9,445 |
Net Debt Issued (Repaid) | -78.98 | -1,806 | -3,291 | -283.2 | -441.32 |
Issuance of Common Stock | 0.62 | 3.14 | 15.28 | - | 30 |
Repurchase of Common Stock | - | - | - | -151.7 | -226.15 |
Common Dividends Paid | -1,091 | -1,812 | -1,127 | -1,033 | -995.9 |
Other Financing Activities | 1,853 | 309.82 | 2,343 | 1,061 | 362.61 |
Financing Cash Flow | 684.03 | -3,304 | -2,059 | -407.26 | -1,271 |
Foreign Exchange Rate Adjustments | -45.93 | -12.78 | 5.19 | 7.93 | -8.27 |
Net Cash Flow | 1,992 | -643.56 | -86.83 | 1,871 | 38.31 |
Free Cash Flow | 1,020 | 2,815 | 3,568 | 2,230 | 1,857 |
Free Cash Flow Growth | -63.78% | -21.11% | 59.98% | 20.13% | 87.82% |
Free Cash Flow Margin | 5.51% | 12.90% | 16.63% | 11.71% | 10.75% |
Free Cash Flow Per Share | 0.64 | 1.78 | 2.31 | 1.50 | 1.31 |
Cash Income Tax Paid | 2,136 | 2,769 | 2,576 | 2,081 | 1,876 |
Levered Free Cash Flow | 700.81 | 1,974 | 1,700 | 1,235 | 1,803 |
Unlevered Free Cash Flow | 765.09 | 2,069 | 1,926 | 1,532 | 2,127 |
Change in Working Capital | -711.32 | -187.19 | 1,249 | -111.89 | 332.01 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.